Modifications in rat plasma proteome after remote ischemic preconditioning (RIPC) stimulus: Identification by a SELDI-TOF-MS approach

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hibert, Pierre ^a,b   Prunier Mirebeau, Delphine ^a,c   Beseme, Olivia ^d,e,f   Chwastyniak, Maggy ^d,e,f   Tamareille, Sophie ^a,b   Pinet, Florence ^d,e,f,g   Prunier, Fabrice ^a,b,h  

^a ISTIA Engineering School   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d INSERM   (France)

^e INSTITUT PASTEUR DE LILLE   (France)

^f UNIV LILLE   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; PREALBUMIN; PROTEOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EXPOSURE; GEL ELECTROPHORESIS; ISCHEMIC PRECONDITIONING; LIMB ISCHEMIA; MALE; MASS SPECTROMETRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEOMICS; RAT; REMOTE ISCHEMIC PRECONDITIONING; REPERFUSION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; ISCHEMIC PRECONDITIONING; MALE; MOLECULAR SEQUENCE DATA; PLASMA; PROTEOME; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84897973070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085669     Document Type: Article

References (51)

1. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136. (Pubitemid 17174962)
2. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, et al. (1997) Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77: 314-318. (Pubitemid 27208169)
3. Walsh SR, Tang TY, Kullar P, Jenkins DP, Dutka DP, et al. (2008) Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg 34: 985-994.
4. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P (1993) Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87: 893-899. (Pubitemid 23070821)
5. Schoemaker RG, van Heijningen CL (2000) Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol 278: H1571-1576. (Pubitemid 30395568)
6. Pell TJ, Baxter GF, Yellon DM, Drew GM (1998) Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. Am J Physiol 275: H1542-1547.
7. Birnbaum Y, Hale SL, Kloner RA (1997) Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 96: 1641-1646. (Pubitemid 27375364)
8. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, et al. (2002) Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106: 2881-2883. (Pubitemid 35424735)
9. Brevoord D, Kranke P, Kuijpers M, Weber N, Hollmann M, et al. (2012) Remote ischemic conditioning to protect against ischemia-reperfusion injury: a systematic review and meta-analysis. PLoS One 7: e42179.
10. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, et al. (2006) Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 47: 2277-2282. (Pubitemid 43795071)
11. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, et al. (2007) Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370: 575-579. (Pubitemid 47247853)
12. Thielmann M, Kottenberg E, Boengler K, Raffelsieper C, Neuhaeuser M, et al. (2010) Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol 105: 657-664.
13. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, et al. (2007) Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 116: I98-105.
14. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, et al. (2009) Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation 119: 820-827.
15. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, et al. (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375: 727-734.
16. Dickson EW, Reinhardt CP, Renzi FP, Becker RC, Porcaro WA, et al. (1999) Ischemic preconditioning may be transferable via whole blood transfusion: preliminary evidence. J Thromb Thrombolysis 8: 123-129.
17. Dickson EW, Lorbar M, Porcaro WA, Fenton RA, Reinhardt CP, et al. (1999) Rabbit heart can be "preconditioned" via transfer of coronary effluent. Am J Physiol 277: H2451-2457. (Pubitemid 30048169)
18. Konstantinov IE, Li J, Cheung MM, Shimizu M, Stokoe J, et al. (2005) Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation 79: 1691-1695. (Pubitemid 40885266)
19. Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, et al. (2009) Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 117: 191-200.
20. Breivik L, Helgeland E, Aarnes EK, Mrdalj J, Jonassen AK (2011) Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion. Basic Res Cardiol 106: 135-145.
21. Dubois E, Richard V, Mulder P, Lamblin N, Drobecq H, et al. (2011) Decreased serine207 phosphorylation of troponin T as a biomarker for left ventricular remodelling after myocardial infarction. Eur Heart J 32: 115-123.
22. Pinet F, Beseme O, Cieniewski-Bernard C, Drobecq H, Jourdain S, et al. (2008) Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis. Proteomics 8: 1798-1808. (Pubitemid 351678280)
23. Acosta-Martin AE, Panchaud A, Chwastyniak M, Dupont A, Juthier F, et al. (2011) Quantitative mass spectrometry analysis using PAcIFIC for the identification of plasma diagnostic biomarkers for abdominal aortic aneurysm. PLoS One 6: e28698.
24. Lang SC, Elsasser A, Scheler C, Vetter S, Tiefenbacher CP, et al. (2006) Myocardial preconditioning and remote renal preconditioning-identifying a protective factor using proteomic methods? Basic Res Cardiol 101: 149-158. (Pubitemid 43250807)
25. Fertin M, Beseme O, Duban S, Amouyel P, Bauters C, et al. (2010) Deep plasma proteomic analysis of patients with left ventricular remodeling after a first myocardial infarction. Proteomics Clin Appl 4: 654-673.
26. Fertin M, Burdese J, Beseme O, Amouyel P, Bauters C, et al. (2011) Strategy for purification and mass spectrometry identification of SELDI peaks corresponding to low-abundance plasma and serum proteins. J Proteomics 74: 420-430.
27. Neuhoff V, Arold N, Taube D, Ehrhardt W (1988) Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9: 255-262.
28. Beseme O, Fertin M, Drobecq H, Amouyel P, Pinet F (2010) Combinatorial peptide ligand library plasma treatment: Advantages for accessing low-abundance proteins. Electrophoresis 31: 2697-2704.
29. Hibert P, Prunier-Mirebeau D, Beseme O, Chwastyniak M, Tamareille S, et al. (2013) Apolipoprotein A-I Is a Potential Mediator of Remote Ischemic Preconditioning. PLoS One 8: e77211.
30. Dickson EW, Blehar DJ, Carraway RE, Heard SO, Steinberg G, et al. (2001) Naloxone blocks transferred preconditioning in isolated rabbit hearts. J Mol Cell Cardiol 33: 1751-1756. (Pubitemid 32844232)
31. Serejo FC, Rodrigues LF Jr, da Silva Tavares KC, de Carvalho AC, Nascimento JH (2007) Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. J Cardiovasc Pharmacol 49: 214-220. (Pubitemid 46626013)
32. Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, et al. (2004) The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics 19: 143-150.
33. Hepponstall M, Ignjatovic V, Binos S, Monagle P, Jones B, et al. (2012) Remote Ischemic Preconditioning (RIPC) Modifies Plasma Proteome in Humans. PLoS One 7: e48284.
34. Quaye IK (2008) Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 102: 735-742.
35. de Kleijn DP, Smeets MB, Kemmeren PP, Lim SK, Van Middelaar BJ, et al. (2002) Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring. FASEB J 16: 1123-1125.
36. Fernandez V, Castillo I, Tapia G, Romanque P, Uribe-Echevarria S, et al. (2007) Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat. Hepatology 45: 170-177. (Pubitemid 46144376)
37. Salvatore A, Cigliano L, Bucci EM, Corpillo D, Velasco S, et al. (2007) Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyltransferase. Biochemistry 46: 11158-11168. (Pubitemid 47502782)
38. Cubedo J, Padro T, Alonso R, Cinca J, Mata P, et al. (2012) Differential proteomic distribution of TTR (pre-albumin) forms in serum and HDL of patients with high cardiovascular risk. Atherosclerosis 222: 263-269.
39. Santos SD, Lambertsen KL, Clausen BH, Akinc A, Alvarez R, et al. (2010) CSF transthyretin neuroprotection in a mouse model of brain ischemia. J Neurochem 115: 1434-1444.
40. Borish L, King MS, Mascali JJ, Johnson S, Coll B, et al. (1992) Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production. Inflammation 16: 471-484.
41. Suzuyama K, Shiraishi T, Oishi T, Ueda S, Okamoto H, et al. (2004) Combined proteomic approach with SELDI-TOF-MS and peptide mass fingerprinting identified the rapid increase of monomeric transthyretin in rat cerebrospinal fluid after transient focal cerebral ischemia. Brain Res Mol Brain Res 129: 44-53. (Pubitemid 39304248)
42. Sousa MM, Berglund L, Saraiva MJ (2000) Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J Lipid Res 41: 58-65. (Pubitemid 30051842)
43. Massberg S, Enders G, Matos FC, Tomic LI, Leiderer R, et al. (1999) Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 94: 3829-3838.
44. Petzelbauer P, Zacharowski PA, Miyazaki Y, Friedl P, Wickenhauser G, et al. (2005) The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 11: 298-304. (Pubitemid 40460558)
45. Krishnamoorthy A, Ajay AK, Hoffmann D, Kim TM, Ramirez V, et al. (2011) Fibrinogen beta-derived Bbeta(15-42) peptide protects against kidney ischemia/reperfusion injury. Blood 118: 1934-1942.
46. Roesner JP, Petzelbauer P, Koch A, Mersmann J, Zacharowski PA, et al. (2007) The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury. Crit Care Med 35: 1730-1735. (Pubitemid 46985877)
47. Zacharowski K, Zacharowski PA, Friedl P, Mastan P, Koch A, et al. (2007) The effects of the fibrin-derived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusion. Shock 27: 631-637. (Pubitemid 46788162)
48. Gerber Y, Goldbourt U, Segev S, Harats D (2003) Indices related to apo CII and CIII serum concentrations and coronary heart disease: a case-control study. Prev Med 37: 18-22. (Pubitemid 36687861)
49. Ooi EM, Barrett PH, Chan DC, Watts GF (2008) Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clin Sci (Lond) 114: 611-624. (Pubitemid 351589061)
50. Yao Z, Wang Y (2012) Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production. Curr Opin Lipidol 23: 206-212.
51. Kawakami A, Yoshida M (2009) Apolipoprotein CIII links dyslipidemia with atherosclerosis. J Atheroscler Thromb 16: 6-11.